Yuki Gosei Kogyo Co., Ltd.

Tokyo Stock Exchange 4531.T

Yuki Gosei Kogyo Co., Ltd. Total Non-Current Liabilities for the year ending March 31, 2024: USD 28.58 M

Yuki Gosei Kogyo Co., Ltd. Total Non-Current Liabilities is USD 28.58 M for the year ending March 31, 2024, a 33.80% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Yuki Gosei Kogyo Co., Ltd. Total Non-Current Liabilities for the year ending March 31, 2023 was USD 21.36 M, a -18.74% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Total Non-Current Liabilities for the year ending March 31, 2022 was USD 26.29 M, a -17.13% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Total Non-Current Liabilities for the year ending March 31, 2021 was USD 31.72 M, a -7.53% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Total Non-Current Liabilities for the year ending March 31, 2020 was USD 34.30 M, a -7.10% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4531.T

Yuki Gosei Kogyo Co., Ltd.

CEO Seiichiro Matsumoto
IPO Date Jan. 4, 2001
Location Japan
Headquarters 10-4, Nihonbashi-Ningyocho 3-chome
Employees 290
Sector Materials
Industries
Description

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.

StockViz Staff

February 2, 2025

Any question? Send us an email